Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL661063 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL29222246 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL252341 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL8620684 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL320819 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL152268 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL735694 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL735689 | 1.00 | SLC34A1 (0.55) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL23722691 | 0.94 | SLC34A1 (0.50) | SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL2901169 | 0.94 | SLC34A1 (0.50) | SLC34A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114890996-B | Heterocyclic compound and organic light-emitting element comprising same | 北京八亿时空液晶科技股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-114957226-B | Phenanthridine derivative and application thereof | 北京八亿时空液晶科技股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-115028630-B | Azaadamantane compound and organic electroluminescent element | 上海八亿时空先进材料有限公司 | 2024-02-06 | — | — | CN | disclosed |
| WO-2023241569-A1 | AZA-ADAMANTANE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT | 上海八亿时空先进材料有限公司 | 2023-12-21 | — | — | WO | disclosed |
| WO-2023236982-A1 | PHENANTHRIDINE DERIVATIVE AND USE THEREOF | 北京八亿时空液晶科技股份有限公司 | 2023-12-14 | — | — | WO | disclosed |
| WO-2023231795-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 北京八亿时空液晶科技股份有限公司 | 2023-12-07 | — | — | WO | disclosed |
| CN-115028630-A | Azaadamantane compound and organic electroluminescent element | 上海八亿时空先进材料有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-114957226-A | Phenanthridine derivative and application thereof | 北京八亿时空液晶科技股份有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-114890996-A | Heterocyclic compound and organic light-emitting element comprising same | 北京八亿时空液晶科技股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-10933056-B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | MERCK SHARP & DOHME CORP. (US) | 2021-03-02 | — | — | US | disclosed |
| EP-3769763-A1 | 3-(1H-PYRAZOL-4-YL) PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | MERCK SHARP & DOHME CORP. (US) | 2021-01-27 | — | — | EP | disclosed |
| EP-3393472-B1 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | MERCK SHARP & DOHME (US) | 2020-08-12 | — | — | EP | disclosed |
| US-20200069671-A1 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | MERCK SHARP & DOHME CORP. (US) | 2020-03-05 | — | — | US | disclosed |
| US-20190000824-A1 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | MERCK SHARP & DOHME CORP. (US) | 2019-01-03 | — | — | US | disclosed |
| EP-2751045-A1 | MAGNESIUM PHOSPHATE BIOMATERIALS | Metallic Organic Ltd. (GB) | 2014-07-09 | — | — | EP | disclosed |
| WO-2013029185-A1 | MAGNESIUM PHOSPHATE BIOMATERIALS | METALLIC ORGANIC LTD (GB) | 2013-03-07 | — | — | WO | disclosed |
| US-20110021625-A1 | NEURONAL CELL DEATH INHIBITOR | LEAD CHEMICAL CO., LTD. (JP) | 2011-01-27 | — | — | US | disclosed |
| EP-2253636-A1 | NEURONAL CELL DEATH INHIBITOR | Lead Chemical Co. Ltd. (JP) | 2010-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200069671-A1 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | CHRM4, CHRM3, CHRM5 | SLC34A1 3096/4885LMNA 4687/4885 |
| US-20110021625-A1 | NEURONAL CELL DEATH INHIBITOR | CASP3, CASP7, CASP2 | SLC34A1 2609/4885LMNA 1531/4885 |
| US-20190000824-A1 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | CHRM4, CHRM5, CHRM3 | SLC34A1 3231/4885LMNA 4667/4885 |
| US-10933056-B2 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | CHRM4, CHRM3, CHRM5 | SLC34A1 3096/4885LMNA 4687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.